KD-414
Vaccine candidate against COVID-19 From Wikipedia, the free encyclopedia
Vaccine candidate against COVID-19 From Wikipedia, the free encyclopedia
KD-414 is a COVID-19 vaccine candidate developed by Japanese biotechnology company KM Biologics Co.[1][2][3] Results of a phase 1/2 clinical trial for this vaccine were released as a preprint in June 2022.[4]
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Inactivated |
Clinical data | |
Routes of administration | Intramuscular |
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.